Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Semin Nephrol. 2003 Jul;23(4):406-11.

Hyperlipidemia and thrombotic complications in patients with membranous nephropathy.

Author information

  • 1Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA.

Abstract

Membranous nephropathy (MN), the most common cause of adult-onset nephrotic syndrome (NS) in Caucasians, is associated commonly with the secondary complications of hyperlipidemia and hypercoagulability. These may increase the risk for cardiovascular disease, alter the rate of progression of renal disease, and raise the risk for thromboembolic events. The treatment of these secondary effects remains controversial. Although no clear practice guidelines are available to assist the clinician in deciding how and when to start disease-modifying therapies, the literature provides enough information to make reasonable decisions in most clinical scenarios. Prospective trials in the future will provide definitive information on how to best treat these abnormalities.

PMID:
12923730
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk